Alexandra Savchenko
About Alexandra Savchenko
Alexandra Savchenko is a Post Doctoral Fellow specializing in Immune Oncology and Cell Therapy, holding dual positions at Bristol Myers Squibb and the University of Alberta.
Title
Alexandra Savchenko holds the position of Post Doctoral Fellow, specializing in Immune Oncology and Cell Therapy. She is currently working at Bristol Myers Squibb in Seattle, Washington, United States and at the University of Alberta in Edmonton, Canada.
Education and Expertise
Alexandra Savchenko has an extensive academic background. She earned her Doctor of Philosophy (PhD) in Biomedical Engineering from the University of Alberta, where she studied from 2011 to 2016. Prior to that, she completed both her Bachelor of Science (BSc) and Master of Science (MSc) in Chemistry at the National University of 'Kyiv-Mohyla Academy' in Ukraine, from 2002 to 2008. Her education spans a combined expertise in chemistry and biomedical engineering.
Background
With over a decade of experience in academia and research, Alexandra Savchenko has cultivated a strong background in the fields of chemistry and biomedical engineering. Her dual fellowship appointments at both the University of Alberta and Bristol Myers Squibb underline her active involvement in research and development within immune oncology and cell therapy. Since January 2022, she has been dedicated to advancing research in this specialized area.
Academic and Research Experience
Alexandra Savchenko has over a decade of academic and research experience, emphasizing her in-depth knowledge in fields such as chemistry and biomedical engineering. Her career has taken her across international borders, allowing her to contribute to significant research projects in both Canada and the United States. Her dual role as a post-doctoral fellow highlights her versatile expertise and dedication to advancing scientific knowledge.
International Research Experience
Alexandra Savchenko’s research journey has an international character, with significant contributions in both Canada and the United States. By holding post-doctoral fellowships at the University of Alberta in Canada and Bristol Myers Squibb in the United States, she brings a unique perspective and diverse set of skills to her work in immune oncology and cell therapy. This broad geographical experience enriches her research approach and collaborative capabilities.